선택적 제품 분석
허용하는 경우 개인정보 보호를 고려한 제한적 분석을 사용해 어떤 리서치 여정이 효과적인지 파악합니다. 광고 추적기나 세션 녹화는 사용하지 않습니다. 환경설정에서 이 선택을 변경할 수 있습니다. 자세한 내용은 개인정보 처리방침.
Fortive Corporation's published Hold conclusion compares the analysis-date price with fair value and potential value. Read the full report for assumptions, evidence, and material risks.
| Market cap | $17.5B | |
|---|---|---|
| Revenue (ttm) | 4.3B | |
| Net income (ttm) | 534.4M | |
| EPS (ttm) | $1.68 | |
| Shares out | 302M | |
| P/E (trailing) | 37.9x | |
| P/E (forward) | 17.3x | |
| Dividend | $0.28 (0.44%) | |
| Volume | 5,333,165 | |
| Beta | 0.99 |
Recent price action with selectable time range.
| Item | P1 | P2 | P3 | P4 | P5 | Trend |
|---|---|---|---|---|---|---|
| Period | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | Trend |
| Revenue | $5.25B | $5.83B | $3.91B | $4.08B | $4.16B | -5.7% |
| Gross profit | $3.01B | $3.36B | $2.48B | $2.62B | $2.64B | -3.2% |
| Operating income | $812.8M | $987.4M | $574.0M | $716.3M | $720.2M | -3.0% |
| Net income | $608.4M | $755.2M | $865.8M | $832.9M | $579.2M | -1.2% |
| EPS (diluted) | $1.23 | $1.58 | $2.43 | $2.36 | $1.73 | +8.9% |
| EBITDA | $1.18B | $1.44B | $1.13B | $1.67B | $1.20B | +0.5% |
| R&D | $354.8M | $401.5M | $237.0M | $251.3M | $259.2M | -7.5% |
| SG&A | $1.84B | $1.96B | $1.67B | $1.65B | $1.66B | -2.5% |
Recent company headlines from major financial publishers.
The base case projects intrinsic value reaching $52.99 with an assigned probability of 60.0%, offering an implied return of -7.5% relative to $57.26 (as of 2026-10-09). This trajectory assumes steady mid-single-digit organic growth across Intelligent Operating Solutions, continuous Fortive Business System operational improvements expanding operating margins through FY2030, and disciplined share repurchases. Disconfirmation would occur if segment operating margins deteriorate or if industrial capex freezes in North America and EMEA.
The bull case models upside reaching $60.16 with a probability of 20.0%, generating an implied return of 5.1% from $57.26 (as of 2026-10-09). This outcome requires accelerated conversion of legacy hardware clients into recurring cloud software subscriptions within Intelligent Operating Solutions, accompanied by stronger hospital procedure volumes in healthcare sterilization. Faster margin expansion toward Potential value of $60.16 would be disconfirmed if peer competition limits software pricing power.
| Ke ↓ / g → | 2.0% | 2.3% | 2.5% | 2.8% | 3.0% |
|---|---|---|---|---|---|
| 8.4% | $56.7 | $57.6 | $58.6 | $59.6 | $60.8 |
| 8.9% | $54.0 | $54.8 | $55.6 | $56.4 | $57.4 |
| 9.4% | $51.7 | $52.3 | $53.0 | $53.7 | $54.5 |
| 9.9% | $49.6 | $50.1 | $50.7 | $51.3 | $52.0 |
| 10.4% | $47.7 | $48.2 | $48.7 | $49.2 | $49.8 |
Upcoming earnings date and setup when available.
매월 발행된 리서치 판이 부여한 등급입니다. 등급은 분석 시점의 가격을 공정 가치와 비교한 것이며, 판단이 맞았는지에 대한 기록이 아닙니다.
| 연도 | 1월 | 2월 | 3월 | 4월 | 5월 | 6월 | 7월 | 8월 | 9월 | 10월 | 11월 | 12월 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 |